Menu Back to Marketing-Pharmaceuticals-2015-Drug-Device-Marketing-in-an-Evolving-Environment


Although Washington DC is experiencing inclement weather, the Marketing Pharmaceuticals Conference will proceed as scheduled.  We look forward to seeing everyone in DC. 

Tutorial:  February 17
OPDP/APLB and Compliance 101: A Primer

Conference: February 18-19 


This conference will explore drug and device marketing in an evolving environment while serving as a vital forum for all stakeholders involved with the marketing, advertising, and promotion of a wide range of health care products.  The importance of understanding the complex regulations regarding the marketing of pharmaceuticals, veterinary products, biologics, and medical devices has never been higher.  Recent actions by the FDA in response to rapidly expanding technologies have left organizations behind in their compliance efforts. 

To understand these recent enforcement actions, this conference features sessions led by those heavily involved in the regulation of marketing pharmaceuticals.  These sessions will offer insight into avoiding regulatory pitfalls while serving as a neutral forum to ask questions.   

Who should attend?

Professionals in pharmaceutical, biologics, veterinary drug and medical device companies involved in:

  • Compliance 
  • Corporate Communications
  • Legal 
  • Marketing 
  • Medical Information and Affairs 
  • Public Relations
  • Regulatory Affairs 
  • Senior Management

Learning objectives

At the conclusion of this meeting, participants should be able to:

  • Identify the trends reflected in the latest enforcement actions and policies issued by the FDA
  • Compare how other companies are complying with government regulatory requirements
  • Discuss best review and approval practices with industry colleagues
  • Assess novel promotional tactics trending in the pharmaceutical industry
  • Identify emerging issues in the oversight of marketing materials

Program Committee

  • Thomas W. Abrams, MBA, RPh
    Thomas W. Abrams, MBA, RPh Director, Office of Prescription Drug Promotion, OMP, CDER FDA, United States
  • Glenn N.  Byrd, MBA, RAC
    Glenn N. Byrd, MBA, RAC Senior Director, Promotional Regulatory Affairs AstraZeneca Specialty Care, United States
  • Dale  Cooke
    Dale Cooke Owner PhillyCooke Consulting , United States
  • Mark  Gaydos
    Mark Gaydos VP & Head, US Specialty Care 2, North America & Global Regulatory Affairs   Sanofi US, United States
  • Lynette  Hopkinson
    Lynette Hopkinson VP Commercial Regulatory Affairs, Global Regulatory Affairs Vertex Pharmaceuticals Incorporated, United States
  • John T. Murray
    John T. Murray President Grayscale Compliance LLC, United States
  • Wayne L. Pines
    Wayne L. Pines President, Regulatory Services and Healthcare APCO Worldwide Inc., United States
  • Janet "Lucy"  Rose, MBA
    Janet "Lucy" Rose, MBA President Lucy Rose and Associates, LLC, United States
  • Kristina   Vlaovic, MPH
    Kristina Vlaovic, MPH Global Regulatory Franchise Head - Ophthalmology & Respiratory Genentech, A Member of the Roche Group, United States
Load More

Contact us

Printable Registration Form

Registration Questions
Toll Free 1.888.257.6457
Phone +1.215.442.6100
Fax +1.215.442.6199
Monday-Friday 8:30AM-8:00PM ET

Agenda Details
Meredith Kaganovskiy, Content Lead
Phone +1.215.442.6117
Fax +1.215.442.6199

Event Logistics
Stephanie Ritter, Event Planner
Phone +1.215.442. 6149
Fax +1.215.442.6199

Exhibit Details
Jessica Culp, Exhibit & Event Logistics Associate 
Phone +1.215.442. 6132
Fax +1.215.442.6199